Related Experiment Videos
Hughes syndrome crosses boundaries.
Guillermo Ruiz-Irastorza1, Munther A Khamashta, Graham R V Hughes
1Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, London SE1 7EH, UK.
Autoimmunity Reviews
|July 10, 2003
Summary
Hughes syndrome, a condition involving antiphospholipid antibodies, has seen diagnostic and management advances. Controversies remain regarding new tests, neurological links, and optimal treatment for thrombosis and obstetric issues.
Area of Science:
- Rheumatology
- Immunology
- Clinical Medicine
Background:
- Antiphospholipid syndrome (APS) is a complex autoimmune disorder characterized by blood clots and pregnancy complications.
- Significant advancements have been made in understanding and managing APS since its initial description.
Purpose of the Study:
- To review recent progress in the diagnosis and management of Hughes (antiphospholipid) syndrome.
- To discuss ongoing controversies and areas of active research in APS.
Main Methods:
- Literature review of recent studies and clinical guidelines.
- Discussion of proposed classification criteria for definite APS.
- Analysis of current evidence regarding diagnostic tests and therapeutic strategies.
Main Results:
- Validated classification criteria for definite APS have been proposed.
- Ongoing debate exists regarding the utility of novel diagnostic tests for antiphospholipid antibodies.
- The role of antiphospholipid antibodies in neurological conditions remains under investigation.
Conclusions:
- While diagnostic and management strategies for APS have evolved, several controversies persist.
- Further research is needed to clarify the role of new diagnostic markers and optimize treatment for thrombosis and obstetric complications in APS.